World's Best Scientists 2026 revealed!
Rasmus Wentzer Licht

Rasmus Wentzer Licht

D-Index & Metrics

Social Sciences and Humanities

D-Index
47
Citations
10620
World Ranking
3363
National Ranking
24

Rasmus Wentzer Licht publication distribution in Social Sciences and Humanities in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Social Sciences and Humanities in 2026. The highlighted bar marks where Rasmus Wentzer Licht sits on this spectrum.

44–53 publications: 28 scientists 54–63 publications: 61 scientists 64–73 publications: 161 scientists 74–83 publications: 225 scientists 84–93 publications: 301 scientists 94–103 publications: 390 scientists 104–113 publications: 406 scientists 114–123 publications: 474 scientists 124–133 publications: 453 scientists 134–143 publications: 434 scientists 144–153 publications: 407 scientists 154–163 publications: 411 scientists 164–173 publications: 391 scientists 174–183 publications: 313 scientists 184–193 publications: 319 scientists 194–203 publications: 304 scientists 204–213 publications: 285 scientists 214–223 publications: 246 scientists 224–233 publications: 213 scientists 234–243 publications: 170 scientists 244–253 publications: 167 scientists 254–263 publications: 162 scientists 264–273 publications: 138 scientists 274–283 publications: 138 scientists 284–293 publications: 113 scientists 294–303 publications: 106 scientists 304–313 publications: 95 scientists 314–323 publications: 101 scientists 324–333 publications: 81 scientists 334–343 publications: 69 scientists 344–353 publications: 56 scientists 354–363 publications: 36 scientists 364–373 publications: 42 scientists 374–383 publications: 41 scientists 384–393 publications: 44 scientists 394–403 publications: 27 scientists 404–413 publications: 30 scientists 414–423 publications: 20 scientists 424–433 publications: 29 scientists 434–443 publications: 29 scientists 444–453 publications: 25 scientists 454–463 publications: 19 scientists 464–473 publications: 21 scientists 474–483 publications: 11 scientists 484–493 publications: 17 scientists 494–503 publications: 7 scientists 504–513 publications: 6 scientists 514–523 publications: 12 scientists 524–533 publications: 10 scientists 534–543 publications: 7 scientists 544–553 publications: 6 scientists 554–563 publications: 12 scientists 564–569 publications: 8 scientists 570+ publications: 100 scientists
44 publications 570+

This scientist: 246 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 570 publications or more.

Rasmus Wentzer Licht D-index placement in Social Sciences and Humanities in 2026

The chart shows the D-index (discipline H-index) distribution of Social Sciences and Humanities scientists ranked by Research.com in 2026. The highlighted bar marks where Rasmus Wentzer Licht sits on this spectrum.

30 D-Index: 177 scientists 31 D-Index: 210 scientists 32 D-Index: 222 scientists 33 D-Index: 188 scientists 34 D-Index: 181 scientists 35 D-Index: 243 scientists 36 D-Index: 261 scientists 37 D-Index: 272 scientists 38 D-Index: 278 scientists 39 D-Index: 300 scientists 40 D-Index: 297 scientists 41 D-Index: 308 scientists 42 D-Index: 313 scientists 43 D-Index: 300 scientists 44 D-Index: 269 scientists 45 D-Index: 260 scientists 46 D-Index: 228 scientists 47 D-Index: 251 scientists 48 D-Index: 203 scientists 49 D-Index: 186 scientists 50 D-Index: 187 scientists 51 D-Index: 166 scientists 52 D-Index: 138 scientists 53 D-Index: 141 scientists 54 D-Index: 131 scientists 55 D-Index: 137 scientists 56 D-Index: 109 scientists 57 D-Index: 129 scientists 58 D-Index: 95 scientists 59 D-Index: 105 scientists 60 D-Index: 106 scientists 61 D-Index: 86 scientists 62 D-Index: 94 scientists 63 D-Index: 77 scientists 64 D-Index: 79 scientists 65 D-Index: 59 scientists 66 D-Index: 68 scientists 67 D-Index: 51 scientists 68 D-Index: 49 scientists 69 D-Index: 40 scientists 70 D-Index: 43 scientists 71 D-Index: 40 scientists 72 D-Index: 50 scientists 73 D-Index: 46 scientists 74 D-Index: 43 scientists 75 D-Index: 45 scientists 76 D-Index: 45 scientists 77 D-Index: 30 scientists 78 D-Index: 25 scientists 79 D-Index: 31 scientists 80 D-Index: 29 scientists 81 D-Index: 18 scientists 82 D-Index: 21 scientists 83 D-Index: 26 scientists 84 D-Index: 15 scientists 85 D-Index: 15 scientists 86 D-Index: 19 scientists 87 D-Index: 19 scientists 88 D-Index: 12 scientists 89 D-Index: 7 scientists 90 D-Index: 19 scientists 91 D-Index: 20 scientists 92 D-Index: 13 scientists 93 D-Index: 9 scientists 94 D-Index: 13 scientists 95 D-Index: 8 scientists 96 D-Index: 7 scientists 97 D-Index: 6 scientists 98 D-Index: 6 scientists 99 D-Index: 6 scientists 100+ D-Index: 97 scientists
30 D-Index 100+

This scientist: 47 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 100 D-Index or more.

Overview

Rasmus Wentzer Licht is affiliated with Aalborg University in Denmark and has conducted extensive research primarily in the fields of Medicine and Psychology. Their work is concentrated within subfields such as Psychiatry and Mental Health, Clinical Psychology, Speech and Hearing, Endocrine and Autonomic Systems, and Social Psychology.

The scientist's research topics include Bipolar Disorder and Treatment, Schizophrenia research and treatment, Adolescent and Pediatric Healthcare, Psychedelics and Drug Studies, Electroconvulsive Therapy Studies, Circadian rhythm and melatonin, and Child and Adolescent Psychosocial and Emotional Development.

Recent papers authored or coauthored by Rasmus Wentzer Licht include:

  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression, 2022, New England Journal of Medicine
  • Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life, 2023, Journal of Affective Disorders
  • DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders network, 2021, European Neuropsychopharmacology
  • Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder, 2021, International Journal of Bipolar Disorders
  • Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action, 2020, European Neuropsychopharmacology

Frequent coauthors of Licht include René Ernst Nielsen, Lars Vedel Kessing, Guy M. Goodwin, Ana González-Pinto, and Andrea Fagiolini.

Licht's research has appeared predominantly in the following publication venues:

  • European Neuropsychopharmacology
  • International Journal of Bipolar Disorders
  • Bipolar Disorders
  • Journal of Affective Disorders
  • European Psychiatry

Best Publications

  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.

    Unknown

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.

    Heinz Grunze;Eduard Vieta;Guy M Goodwin;Charles Bowden

  • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.

    Heinz Grunze;Eduard Vieta;Guy M. Goodwin;Charles Bowden

  • Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

    Mauricio Tohen;Waldemar Greil;Joseph R. Calabrese;Gary S. Sachs

  • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania

    Heinz Grunze;Eduard Vieta;Guy M Goodwin;Charles Bowden

  • World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Bipolar Disorders, Part I: Treatment of Bipolar Depression

    Heinz Grunze;Siegfried Kasper;Guy Goodwin;Charles Bowden

  • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.

    Heinz Grunze;Siegfried Kasper;Guy Goodwin;Charles Bowden

  • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the Treatment of Acute Bipolar Depression

    Heinz Grunze;Eduard Vieta;Guy M. Goodwin;Charles Bowden

  • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part III: Maintenance Treatment

    Heinz Grunze;Siegfried Kasper;Guy Goodwin;Charles Bowden

  • Lithium: still a major option in the management of bipolar disorder.

    Rasmus W Licht

  • Clinical use of lithium salts: guide for users and prescribers

    Leonardo Tondo;Leonardo Tondo;Martin Alda;Michael Bauer;Veerle Bergink;Veerle Bergink

  • Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

    Guy Goodwin;Wolfgang Fleischhacker;Celso Arango;Pierre Baumann

  • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder

    Heinz Grunze;Eduard Vieta;Guy M. Goodwin;Charles Bowden

  • Use of Lithium and Anticonvulsants and the Rate of Chronic Kidney Disease: A Nationwide Population-Based Study

    Lars Vedel Kessing;Thomas Alexander Gerds;Bo Feldt-Rasmussen;Per Kragh Andersen

  • Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.

    Unknown

  • Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression; is the total score a valid measure of illness severity?

    R. W. Licht;S. Qvitzau;P. Allerup;P. Bech

  • Evidence for a role of phospholipase C-gamma1 in the pathogenesis of bipolar disorder.

    G Turecki;P Grof;P Cavazzoni;A Duffy

  • Family History of Psychiatric Illness as a Risk Factor for Schizoaffective Disorder: A Danish Register-Based Cohort Study

    Thomas Munk Laursen;Rodrigo Labouriau;Rasmus Wentzer Licht;Aksel Bertelsen

  • Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration.

    R. W. Licht;H. Gijsman;W. A. Nolen;J. Angst

  • Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation.

    Rasmus W. Licht;Susanne Qvitzau

  • Serum concentrations and side effects in psychiatric patients during risperidone therapy.

    Ole V. Olesen;Rasmus W. Licht;Erik Thomsen;Troels Bruun

Frequent Co-Authors

Eduard Vieta
Eduard Vieta University of Barcelona
Guy M. Goodwin
Guy M. Goodwin University of Oxford
Lars Vedel Kessing
Lars Vedel Kessing University of Copenhagen
Heinz Grunze
Heinz Grunze Paracelsus Medical University
Michael Berk
Michael Berk Deakin University
Seetal Dodd
Seetal Dodd Deakin University
Michael Bauer
Michael Bauer TU Dresden
Siegfried Kasper
Siegfried Kasper Medical University of Vienna
Charles L. Bowden
Charles L. Bowden The University of Texas Health Science Center at San Antonio
Martin Alda
Martin Alda Dalhousie University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The landscape for Social Sciences and Humanities education in the USA is evolving quickly, especially with the rise of flexible online options. If you’re interested in helping others, pursuing a masters in social work online can equip you with the skills needed for diverse roles in community service, healthcare, and advocacy.

Those drawn to understanding human behavior may benefit from accelerated psychology degree programs. These programs enable students to complete their studies faster and start their careers in psychology, research, or social services sooner.

For students focused on guiding others through personal or emotional challenges, there are cacrep-accredited programs online that meet national standards for counseling education—an important step toward licensure.

Similarly, those interested in supporting couples and families can explore a marriage and family therapist degree delivered online, preparing for impactful careers in mental health and relationship counseling.

These online pathways make advanced study more accessible, providing flexible options for a wide range of rewarding careers in the social sciences and humanities.

Best Scientists Citing Rasmus Wentzer Licht

Trending Scientists

Recently Published Articles